Found 42 matching trials
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis PHASE2 This is a dose-ranging study designed to investigate the efficacy and safet...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Therapeutics for Moderate and Severe Dengue PHASE3 The purpose of this multi-site, factorial randomised, platform trial is to ...
Show More Location
Chittagong Medical College Hospital
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis PHASE4 Systemic Sclerosis (Ssc) is a rare, systemic autoimmune disease characteriz...
Show More Status
Active Not Recruiting
Location
Department of RheumatologyTongji Hospital
Learn More & Join Trial
Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid PHASE2 Ocular mucous membrane pemphigoid (MMP) is an autoimmune, scarring conjunct...
Show More Location
Barnes Jewish Hospital / Washington University in St. Louis
Learn More & Join Trial
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial PHASE2 PALETTE is a perpetual adaptive platform to efficiently study sepsis interv...
Show More Location
CHU Dijon - infectiologie
Learn More & Join Trial
Baricitinib Curative Repression of HIV-1 PHASE2 This study is being done to test whether a drug called baricitinib, which b...
Show More Location
Grady Infectious Diseases Clinic (Ponce Center)
Learn More & Join Trial
Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury PHASE1 Some patients with intracerebral hemorrhage will develop severe lung injury...
Show More Location
Tianjin Medical University General Hospital
Learn More & Join Trial
A Study of Baricitinib in Participants With Rheumatoid Arthritis PHASE4 This post-marketing study is designed to compare the safety of baricitinib ...
Show More Location
Arizona Research Clinic PLLC
Learn More & Join Trial
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) PHASE4 TACTIC-R is a randomised, parallel arm, open-label platform trial for inves...
Show More Location
Cambridge University Hospitals NHS Foundation Trust
Learn More & Join Trial
Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation PHASE1 Background:
Chronic graft versus host disease (cGVHD) can affect people wh...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial